BRÈVE

sur EBD Group

BIO-Europe Spring 2026 Looks to Lisbon for Life Sciences Innovation

The BIO-Europe Spring 2026 conference will unfold in Lisbon, Portugal, from March 23 to 25, with an additional digital event on March 31 to April 1. This marks the first joint occurrence with LSX Europe during the Life Sciences Spring Innovation Week, creating an invaluable platform for global partnerships.

The event expects over 3,700 participants from across the life sciences sector, including academia, biotech startups, pharmaceutical leaders, and investors. Scheduled are more than 20,000 meetings aimed at fostering strategic collaborations.

Lisbon is recognized for its vibrant life sciences ecosystem, featuring competitive pharmaceutical activity, premier research institutions, and a budding venture capital scene. The BIO-Europe Spring 2026 program promises a diverse array of sessions, such as discussions on biotech partnering, AI in drug development, and global investment trends.

R. P.

Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.

Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève

Voir toutes les actualités de EBD Group